Advanced search
Publication Cover
Autoimmunity Volume 48, 2015 - Issue 8
Submit an article Journal homepage
213
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?

Marlies KeijzersDepartment of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht and GROW Research institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands,
,
Jan DamoiseauxCentral Diagnostic Laboratory, Maastricht University Medical Centre, Maastricht, The Netherlands,
,
Alain VigneronD-TEK, Mons, Belgium,
,
Nicolas BodartD-TEK, Mons, Belgium,
,
Alfons KesselsClinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands,
,
Anne-Marie C. DingemansDepartment of Pulmonology, Maastricht University Medical Centre, Maastricht, The Netherlands, ;GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands,
,
Monique Hochstenbag
,
Jos MaessenDepartment of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands, ;CARIM School for cardiovascular diseases, Maastricht University, Maastricht, The Netherlands, and
&
Marc De BaetsDepartment of Neuroscience, Maastricht University Medical Centre, Maastricht, The NetherlandsCorrespondence[email protected]
 show all
Pages 552-555 | Received 22 Dec 2014, Accepted 08 Jun 2015, Published online: 30 Jul 2015

References

  • Simpson, J. A. 1958. An evaluation of thymectomy in myasthenia gravis. Brain 81: 112–144
  • Simpson, J A. 1966. Myasthenia gravis as an autoimmune disease: clinical aspects. Ann. NY Acad. Sci. 135: 506–516
  • Marx, A., F. Pfister, B. Schalke, et al. 2013. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun. Rev. 12: 875–884
  • Diaz-Manera, J., R. Rojas Garcia, Illa, I. 2012. Treatment strategies for myasthenia gravis: an update. Expert Opin. Pharmacother. 13: 1873–1883
  • Park, I. K., S. S. Choi, J. Lee, et al. 2006. Complete stable remission after extended transsternal thymectomy in myasthenia gravis. Eur. J. Cardio-Thoracic Surg. 30: 525–528
  • Masaoka, A., Y. Yamakawa, H. Niwa, et al. 1996. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann. Thoracic Surg. 62: 853–859
  • Keijzers, M., M. de Baets, M. Hochstenbag, et al. 2015. Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes. Eur. J. Cardio-Thoracic Surg. 48: 40–45
  • Jaretzki, A., III R. J. Barohn, R. M. Ernstoff, et al. 2000. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 55: 16–23
  • Oosterhuis, H. J., P. C. Limburg, E. Hummel-Tappel, et al. 1983. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients. J. Neurol. Sci. 58: 371–385
  • Vrolix, K., J. Fraussen, P. C. Molenaar, et al. 2010. The auto-antigen repertoire in myasthenia gravis. Autoimmunity. 43: 380–400
  • Simpson, J. A. 1960. Myasthenia Gravis: a new hypothesis. Scott. Med. J. 5: 419–436
  • Klein, R., A. Marx, P. Strobel, et al. 2013. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis. Hum. Immunol. 74: 1184–1193
  • Mao, Z. F., L. X. Yang, X. A. Mo, et al. 2011. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int. J. Neurosci. 121: 121–129
  • Oosterhuis, H. J. G. H. 1984. Clinical Neurology and Neurosurgery Monographs. Myasthenia Gravis. Vol. 5. Churchill Livingstone, New York
  • Monden, Y., T. Uyama, K. Nakahara, et al. 1986. Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases. Ann. Thorac. Surg. 41: 189–192
  • Tellez-Zenteno, J. F., G. Cardenas, B. Estanol, et al. 2004. Associated conditions in myasthenia gravis: response to thymectomy. Eur. J. Neurol. 11: 767–773
  • Arbuckle, M. R., M. T. McClain, M. V. Rubertone, et al. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Eng. J. Med. 349: 1526–1533
  • Avidan, N., R. Le Panse, H. F. Harbo, et al. 2014. VAV1 and BAFF, via NFkappaB pathway, are genetic risk factors for myasthenia gravis. Ann. Clin. Transl. Neurol. 1: 329–339
  • Gregersen, P. K., R. Kosoy, A. T. Lee, et al. 2012. Risk for myasthenia gravis maps to a (151) Pro–>Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann. Neurol. 72: 927–935
  • Souadjian, J. V., P. Enriquez, M. N. Silverstein, J. M. Pepin. 1974. The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch. Int. Med. 134: 374–379

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.